{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:57:53Z","timestamp":1782478673041,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To investigate whether post-prostate artery embolization (PAE) magnetic resonance imaging (MRI) can predict clinical outcomes at 1 year.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>Retrospective study of 63 consecutive patients undergoing microsphere PAE for benign prostatic enlargement. Clinical assessments were performed with the International Prostate Symptom Score (IPSS), quality of life (QoL) scores, and non-invasive urodynamics. MRI was performed at baseline and 3-month post-PAE: intravesical protrusion, prostate volume (PV), and infarction volumes were measured with semi-automated volumetry. Clinical success was defined as (1) a reduction of IPSS to\u2009&lt;\u20099 and QoL score to\u2009&lt;\u20093 or (2) freedom from urinary catheter in catheter-dependent patients. Statistical modeling was performed with multivariate logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Sixty-three patients were included. Median PV 116\u00a0ml (IQR 85\u2013153); median PV reduction 26% (IQR 19\u201345) at 3\u00a0months. Presence of infarction on 3-month MRI was associated with clinical success at 12\u00a0months (OR\u2009=\u20091.15, 95% CI: 1.04\u20131.36,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.025). A receiver operator curve analysis of infarct volume returned an area under the curve of 0.77 (CI 0.66\u20130.89) and indicated that an infarct volume\u2009\u2265\u20095% had a sensitivity of 72% and specificity of 80% to predict clinical success. PV reduction did not show statistically significant correlation with clinical success (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.348, 95% CI: 0.98\u20131.08). A lower baseline IPSS was correlated with better clinical outcomes (OR 0.78; 95% CI 0.64\u20130.91;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003). Other clinical and anatomical variables including intravesical protrusion were not correlated with clinical outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Lower baseline IPSS and presence of infarction of\u2009&gt;\u20095% on 3-month post-PAE MRI were associated with better clinical outcomes at 12\u00a0months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s00270-025-04254-w","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:04:33Z","timestamp":1762211073000},"page":"370-379","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Three-Month Magnetic Resonance Imaging Post-Prostate Artery Embolization Predicts 1-Year Clinical Outcomes"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3088-2775","authenticated-orcid":false,"given":"Conrad","family":"von Stempel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lazaros","family":"Tzelves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhmani","family":"Khangura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakup","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles","family":"Walkden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Al-Nowfal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Munneke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Mazzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafer","family":"Tando\u011fdu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"issue":"2","key":"4254_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00270-020-02657-5","volume":"44","author":"GM Knight","year":"2021","unstructured":"Knight GM, Talwar A, Salem R, Mouli S. Systematic review and meta-analysis comparing prostatic artery embolization to gold-standard transurethral resection of the prostate for benign prostatic hyperplasia. Cardiovasc Intervent Radiol Springer. 2021;44(2):183\u201393. https:\/\/doi.org\/10.1007\/s00270-020-02657-5.","journal-title":"Cardiovasc Intervent Radiol Springer"},{"issue":"3","key":"4254_CR2","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.eururo.2019.11.010","volume":"77","author":"JM Pisco","year":"2020","unstructured":"Pisco JM, Bilhim T, Costa NV, et al. Randomised clinical trial of prostatic artery embolisation versus a sham procedure for benign prostatic hyperplasia[formula presented]. Eur Urol. 2020;77(3):354. https:\/\/doi.org\/10.1016\/j.eururo.2019.11.010.","journal-title":"Eur Urol"},{"issue":"1","key":"4254_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.eururo.2021.02.008","volume":"80","author":"D Abt","year":"2021","unstructured":"Abt D, M\u00fcllhaupt G, Hechelhammer L, et al. Prostatic artery embolisation versus transurethral resection of the prostate for benign prostatic hyperplasia: 2-yr outcomes of a randomised, open-label, single-centre trial[formula presented]. Eur Urol. 2021;80(1):34\u201342. https:\/\/doi.org\/10.1016\/j.eururo.2021.02.008.","journal-title":"Eur Urol"},{"issue":"9","key":"4254_CR4","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1007\/s00270-022-03199-8","volume":"45","author":"T Bilhim","year":"2022","unstructured":"Bilhim T, Costa NV, Torres D, Pinheiro LC, Spaepen E. Long-term outcome of prostatic artery embolization for patients with benign prostatic hyperplasia: single-centre retrospective study in 1072 patients over a 10-year period. Cardiovasc Intervent Radiol. 2022;45(9):1324\u201336. https:\/\/doi.org\/10.1007\/s00270-022-03199-8.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"11","key":"4254_CR5","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1016\/j.jvir.2016.08.004","volume":"27","author":"A Uflacker","year":"2016","unstructured":"Uflacker A, Haskal ZJ, Bilhim T, Patrie J, Huber T, Pisco JM. Meta-analysis of prostatic artery embolization for benign prostatic hyperplasia. J Vasc Interv Radiol. 2016;27(11):1686-1697.e8. https:\/\/doi.org\/10.1016\/j.jvir.2016.08.004.","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"4254_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s00270-015-1202-4","volume":"39","author":"FC Carnevale","year":"2016","unstructured":"Carnevale FC, Iscaife A, Yoshinaga EM, Moreira AM, Antunes AA, Srougi M. Transurethral resection of the prostate (TURP) versus original and perfected prostate artery embolization (PAE) due to benign prostatic hyperplasia (BPH): preliminary results of a single center, prospective Urodynamic-Controlled Analysis. Cardiovasc Intervent Radiol. 2016;39(1):44\u201352. https:\/\/doi.org\/10.1007\/s00270-015-1202-4.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"4254_CR7","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2016152292","author":"T Bilhim","year":"2016","unstructured":"Bilhim T, Pisco J, Pereira JA, et al. Predictors of clinical outcome after prostate artery embolization with spherical and nonspherical polyvinyl alcohol particles in patients with benign prostatic hyperplasia. Radiology. 2016. https:\/\/doi.org\/10.1148\/radiol.2016152292.","journal-title":"Radiology"},{"key":"4254_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-018-02156-8","author":"N Hacking","year":"2019","unstructured":"Hacking N, Vigneswaran G, Maclean D, et al. Technical and imaging outcomes from the UK registry of prostate artery embolization (UK-rope) study: focusing on predictors of clinical success. Cardiovasc Intervent Radiol. 2019. https:\/\/doi.org\/10.1007\/s00270-018-02156-8.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"4254_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-017-1602-8","author":"MW Little","year":"2017","unstructured":"Little MW, Boardman P, Macdonald AC, et al. Adenomatous-dominant benign prostatic hyperplasia (AdBPH) as a predictor for clinical success following prostate artery embolization: an age-matched case-control study. Cardiovasc Intervent Radiol. 2017. https:\/\/doi.org\/10.1007\/s00270-017-1602-8.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"4254_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14632","author":"D Abt","year":"2019","unstructured":"Abt D, M\u00fcllhaupt G, Mordasini L, et al. Outcome prediction of prostatic artery embolization: post hoc analysis of a randomized, open-label, non-inferiority trial. BJU Int. 2019. https:\/\/doi.org\/10.1111\/bju.14632.","journal-title":"BJU Int"},{"issue":"11","key":"4254_CR11","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.jvir.2019.07.035","volume":"30","author":"SCH Yu","year":"2019","unstructured":"Yu SCH, Cho CCM, Hung EHY, et al. Thickness-to-Height Ratio of Intravesical Prostatic Protrusion Predicts the Clinical Outcome and Morbidity of Prostatic Artery Embolization for Benign Prostatic Hyperplasia. J Vasc Interv Radiol. 2019;30(11):1807\u201316. https:\/\/doi.org\/10.1016\/j.jvir.2019.07.035.","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"4254_CR12","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2214\/AJR.13.11692","volume":"203","author":"NE Frenk","year":"2014","unstructured":"Frenk NE, Baroni RH, Carnevale FC, et al. MRI findings after prostatic artery embolization for treatment of benign hyperplasia. Am J Roentgenol. 2014;203(4):813\u201321. https:\/\/doi.org\/10.2214\/AJR.13.11692.","journal-title":"Am J Roentgenol"},{"key":"4254_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-015-4177-2","author":"YT Lin","year":"2016","unstructured":"Lin YT, Amouyal G, Correas JM, et al. Can prostatic arterial embolisation (PAE) reduce the volume of the peripheral zone? MRI evaluation of zonal anatomy and infarction after PAE. Eur Radiol. 2016. https:\/\/doi.org\/10.1007\/s00330-015-4177-2.","journal-title":"Eur Radiol"},{"key":"4254_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-015-1267-0","author":"G Amouyal","year":"2016","unstructured":"Amouyal G, Thiounn N, Pellerin O, et al. Clinical results after prostatic artery embolization using the PErFecTED technique: a single-center study. Cardiovasc Intervent Radiol. 2016. https:\/\/doi.org\/10.1007\/s00270-015-1267-0.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"6","key":"4254_CR15","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1007\/s00270-014-0908-z","volume":"37","author":"FC Carnevale","year":"2014","unstructured":"Carnevale FC, Moreira AM, Antunes AA. The \u201cPErFecTED technique\u201d: proximal embolization first, then embolize distal for benign prostatic hyperplasia. Cardiovasc Intervent Radiol. 2014;37(6):1602\u20135. https:\/\/doi.org\/10.1007\/s00270-014-0908-z.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"4","key":"4254_CR16","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00270-015-1114-3","volume":"38","author":"AM de Assis","year":"2015","unstructured":"de Assis AM, Moreira AM, de Paula Rodrigues VC, et al. Pelvic arterial anatomy relevant to prostatic artery embolisation and proposal for angiographic classification. Cardiovasc Intervent Radiol. 2015;38(4):855\u201361. https:\/\/doi.org\/10.1007\/s00270-015-1114-3.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"4254_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-017-1703-4","author":"DK Filippiadis","year":"2017","unstructured":"Filippiadis DK, Binkert C, Pellerin O, Hoffmann RT, Krajina A, Pereira PL. Cirse quality assurance document and standards for classification of complications: the cirse classification system. Cardiovasc Intervent Radiol. 2017. https:\/\/doi.org\/10.1007\/s00270-017-1703-4.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"4254_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/S0302-2838(03)00199-4","author":"SJ Hong","year":"2003","unstructured":"Hong SJ, Ko WJ, Il KS, Chung BH, Djavan B. Identification of baseline clinical factors which predict medical treatment failure of benign prostatic hyperplasia: An observational cohort study. Eur Urol. 2003. https:\/\/doi.org\/10.1016\/S0302-2838(03)00199-4.","journal-title":"Eur Urol"},{"issue":"3","key":"4254_CR19","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1148\/radiol.2463070647","volume":"246","author":"F Sun","year":"2008","unstructured":"Sun F, S\u00e1nchez FM, Cris\u00f3stomo V, et al. Benign prostatic hyperplasia: transcatheter arterial embolization as potential treatment - preliminary study in pigs. Radiology. 2008;246(3):783\u20139. https:\/\/doi.org\/10.1148\/radiol.2463070647.","journal-title":"Radiology"},{"key":"4254_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-015-1238-5","author":"F Sun","year":"2016","unstructured":"Sun F, Cris\u00f3stomo V, B\u00e1ez-D\u00edaz C, S\u00e1nchez FM. Prostatic artery embolization (PAE) for symptomatic benign prostatic hyperplasia (BPH): part 2, insights into the technical rationale. Cardiovasc Intervent Radiol. 2016. https:\/\/doi.org\/10.1007\/s00270-015-1238-5.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"7","key":"4254_CR21","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00270-019-02220-x","volume":"42","author":"AM de Assis","year":"2019","unstructured":"de Assis AM, Moreira AM, Carnevale FC, et al. Effects of prostatic artery embolization on the dynamic component of benign prostate hyperplasia as assessed by ultrasound elastography: a pilot series. Cardiovasc Intervent Radiol. 2019;42(7):1001\u20137. https:\/\/doi.org\/10.1007\/s00270-019-02220-x.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"4254_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13147","author":"M Wang","year":"2016","unstructured":"Wang M, Guo L, Duan F, et al. Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates. BJU Int. 2016. https:\/\/doi.org\/10.1111\/bju.13147.","journal-title":"BJU Int"},{"issue":"9","key":"4254_CR23","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1007\/s00330-012-2714-9","volume":"23","author":"JM Pisco","year":"2013","unstructured":"Pisco JM, Rio Tinto H, Campos Pinheiro L, et al. Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: Results of short- and mid-term follow-up. Eur Radiol. 2013;23(9):2561\u201372. https:\/\/doi.org\/10.1007\/s00330-012-2714-9.","journal-title":"Eur Radiol"},{"key":"4254_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-022-03069-3","author":"E Salet","year":"2022","unstructured":"Salet E, Cromb\u00e9 A, Grenier N, et al. Prostatic artery embolization for benign prostatic obstruction: single-centre retrospective study comparing microspheres versus n-butyl cyanoacrylate. Cardiovasc Intervent Radiol. 2022. https:\/\/doi.org\/10.1007\/s00270-022-03069-3.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"4254_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.diii.2023.12.006","author":"R Loffroy","year":"2024","unstructured":"Loffroy R, Quirantes A, Guillen K, et al. Prostate artery embolization using n-butyl cyanoacrylate glue for symptomatic benign prostatic hyperplasia: A six-month outcome analysis in 103 patients. Diagn Interv Imaging. 2024. https:\/\/doi.org\/10.1016\/j.diii.2023.12.006.","journal-title":"Diagn Interv Imaging"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-025-04254-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-025-04254-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-025-04254-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T15:04:02Z","timestamp":1770131042000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-025-04254-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["4254"],"URL":"https:\/\/doi.org\/10.1007\/s00270-025-04254-w","relation":{},"ISSN":["1432-086X"],"issn-type":[{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"14 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"For this type of study, informed consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"For this type of study, consent for publication is not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}